Startseite Prone position effect in intensive care patients with SARS-COV-2 pneumonia
Artikel Open Access

Prone position effect in intensive care patients with SARS-COV-2 pneumonia

  • Sandra Manuela Rebelo Oliveira , Alexandra Marisa da Silva Ferreira , Paulo Jorge Ventura Silva , Cristina Susana Sousa Pinto , Maria Glória Cabral Campello und Amâncio António de Sousa Carvalho EMAIL logo
Veröffentlicht/Copyright: 27. Juni 2023

Abstract

Ventilation in the prone position (PP) has been used for decades in patients with acute respiratory distress syndrome (ARDS) and is associated with a reduction in mortality rate. Its application has been extended to patients with SARS-Cov-2 pneumonia and is recommended by the main international organizations. The objective is to evaluate the effects of PP on the outcomes of patients with SARS-Cov-2 pneumonia admitted to a multipurpose intensive care unit. This is a quantitative, quasi-experimental, single-group, longitudinal and retrospective study. Data were collected based on clinical records. Data were processed using SPSS (version 26.0). PP significantly increased oxygenation in patients with SARS-Cov-2 pneumonia, with a mean increase of 21.27% between the PaO2/FiO2 ratio before and after the PP. However, its effectiveness was inversely proportional to the number of cycles performed and the timing of orotracheal intubation. PP improves oxygenation in patients with SARS-Cov-2 pneumonia. However, multiple PP sessions are not beneficial, as this procedure is no longer effective after the fourth cycle. This study thus contributes to better management in the approach of critically ill patients with SARS-Cov-2 pneumonia.

1 Introduction

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which emerged as a new human pathogen in China in late 2019, is responsible for coronavirus disease 2019 (COVID-19), and is the seventh member of the human coronavirus family, causing symptoms such as cough and fever, severe pneumonia and death, assuming pandemic characteristics [1,2].

Approximately 5–20% of patients with SARS-Cov-2 pneumonia are admitted to intensive care units (ICUs), with a mortality rate between 26 and 61.5%. Most patients present respiratory failure and over 88% require invasive mechanical ventilation (IMV) [3,4]. Age, body mass index (BMI) > 25 kg/m2, as well as a history of oncological, cerebrovascular, chronic kidney disease, chronic obstructive pulmonary disease, diabetes mellitus (DM), heart diseases (cardiomyopathies, heart failure, coronary heart disease), hypertension, and smoking (past or present), among others, have been identified as risk factors associated with the development of severe disease [5].

Ventilation in the prone position (PP) has been used for decades in acute respiratory distress syndrome (ARDS) and is recommended by the main international health organizations as an alveolar recruitment maneuver to improve oxygenation [6], and is considered a safe strategy associated with a reduced mortality rate in patients with moderate to severe ARDS [6,7,8,9], according to the current Berlin definition [10].

Based on the pathophysiology and results of PP in patients with ARDS, its application was extended to patients with SARS-Cov-2 pneumonia and is recommended by the World Health Organization (WHO) and the Surviving Sepsis Campaign for a period of 12–16 h in patients under IMV with COVID-19 and moderate to severe ARDS [11,12]. In Portugal, the Sociedade Portuguesa de Cuidados Intensivos (SPCI) and the Infeção e Sépsis Group issued recommendations for the approach to COVID-19 in intensive care medicine, advising early PP if arterial oxygen pressure/inspired oxygen fraction (PaO2/FiO2) ratio <150 mmHg, for minimum periods of 16 h and with use of neuromuscular blockers (NMB) for ≤48 h if frequent dyssynchrony [13]. The pressure exerted by the pandemic has led health systems worldwide to develop strategies to manage available resources. In this context, studies have emerged recommending the extension of the duration of PP up to 36 h, arguing that there is an improvement in the PaO2/FiO2 ratio higher compared to conventional PP (16 h), remaining significantly higher in the return to dorsal decubitus (DD), with a reduction in the number of PP cycles performed [3,14]. The need to optimize resources led to the extension of the applicability of PP to awake patients under supplemental oxygen, high-flow oxygen therapy (HFO), and non-invasive ventilation (NIV), with improved oxygenation and with the advantage that it can be performed in an inpatient setting [15,16]. However, the literature is not consensual and there are studies showing that the response of these patients to PP is very varied and that the improvement in oxygenation obtained does not translate into clinical improvement or favorable radiological evolution, suggesting that PP does not offer more benefits than a transitory improvement in oxygenation [17,18]. Regarding the use of PP in conscious patients, the literature is equally controversial and there is no evidence that PP in these patients reduces the need for orotracheal intubation (OTI) and in some cases, there is a delay in OTI and increase in emergency OTI [3,19].

Based on these considerations and to improve the approach to patients with SARS-Cov-2 pneumonia in future situations, a research study was carried out at the Hospitalar Centre of Tâmega and Sousa (CHTS) Multipurpose Intensive Care Unit (MICU) with the aim of assessing the effects of PP on the outcomes of patients with SARS-Cov-2 pneumonia.

2 Methods

2.1 Type of study

This is a quantitative approach, quasi-experimental single-group, longitudinal and retrospective study.

2.2 Population and sample

The sampling method selected was non-probabilistic sampling by rational choice, with the individuals being selected according to a set of pre-defined inclusion criteria in order to represent the phenomenon under study, with the main limitation of this technique being less reliable than probabilistic methods when it comes to generalizing the results to our population [20].

Patients admitted to the MICU under study, diagnosed with SARS-Cov-2 pneumonia, and submitted to IMV and PP between March 23 and December 27, 2020 were included in the study. The application of the inclusion and exclusion criteria resulted in a sample of 52 patients.

The research followed all ethical principles, in accordance with the Helsinki standards, and the research was approved by the Ethics Committee of the CHTS.

2.3 Instrument for data collection

Data collection was carried out by consulting clinical files.

2.4 Operationalization and categorization of variables

The variables under study were divided into eight groups, namely:

  1. Demographic data encompassing the variables: gender and age.

  2. Clinical data, where the variables are inserted: BMI, diagnostic category, relevant antecedents, provenance and nursing manpower use (NMU).

  3. Disease chronology, which covers the following variables: onset of symptoms, timing to MICU and timing to OTI.

  4. Adjuvant therapies encompass the use of NMB, amines, tracheostomies and extracorporeal membrane oxygenation (ECMO).

  5. PP characteristics include the variables: timing to first PP, number of PP cycles per patient and PP time.

Gasometric data including oxygenation translated by the PaO2/FiO2 ratio were assessed at three different moments: before PP (T0), during PP (T1) and after PP (T2 (at the return to the DD), by means of control gasometry collected 1–3 h before, during and after PP.

The response to PP was classified as follows: no response, poor response, good response and very good response, according to the evolution of the PaO2/FiO2 ratio before and after PP; patients who presented a mean PaO2/FiO2 ratio after PP lower than before PP were considered no responders to PP. In order to classify the response to PP, the mean percentage of variation between the PaO2/FiO2 ratio before and after PP was assessed; a variation below the mean was considered a poor response to PP [19]; a variation between the mean and twice the mean was considered a good response and a very good response when the variation in the PaO2/FiO2 ratio before and after PP was more than twice the mean variation.

2.5 Data analysis

For data processing, a database was built in the Statistical Program for Data Processing in Social Sciences (SPSS, version 26.0), in which they were edited, considering a type I error probability (α) of 0.05. Data were analyzed using descriptive statistics by calculating the absolute and relative frequencies for all variables and the measures of central tendency and dispersion for the ratio measurement level variables. In addition, inferential statistics was performed using the ANOVA test of repeated measurements to assess the significance of the effectiveness of the positioning in PP on the PaO2/FiO2 ratio and the evolution of this ratio in the three moments under analysis. Multivariate analysis using an ordinal regression model was also used to test the influence of independent variables (demographic variables, relevant clinical history, disease chronology and PP characteristics) on the dependent variable “response to PP.” Then, the Kruskal–Wallis test was used to compare the means of ordination of the categories of the dependent variables (duration of IMV and length of stay in the MICU) according to the response to PP. Finally, we used the χ 2 test to check for statistical differences between the response to PP regarding the incidence of tracheostomy and mortality rate.

3 Results

From the total sample (n = 52 patients), there was a predominance of males (57.7%), with a mean age of 63.9 ± 10.2 years (Δ42–83). Most patients (69.2%) had relevant clinical history, the most frequent being hypertension (HT) (77.8%), DM (47.2%) and obesity (38.5%); the mean BMI was 28.86 ± 5.27 (Δ20–44.4). The mean NMU of these patients was 31.54 ± 3.61.

The onset of symptoms appeared on average 6.6 ± 3.9 days before hospital admission, and they were transferred to the MICU at 2.5 ± 3(2) days of admission.

In the MICU, OTI was performed within the first 15.3 ± 30.3(1) h after admission. Patients remained ventilated for a mean period of 13 ± 9.7 days, with a mean stay in the MICU of 15.9 ± 11 days. Almost all patients (98.1%) required NMB, 98.1% required aminergic support, 5.8% were transferred to other hospital units and submitted to extracorporeal oxygenation membrane (ECMO) and 17.3% were tracheostomized. The mortality rate was 50%.

The first PP cycle occurred, on average, 45.7 ± 61.2(21) h after OTI. Each patient performed an average of 2.8 ± 1.6 cycles, lasting 20.5 ± 3.7 h.

The mean PaO2/FiO2 ratio before starting PP was 115.6 ± 38.2 in PP of 159.1 ± 65.4 and after undoing PP of 140.1 ± 48.9. It was found that 23.1% of the patients did not respond to PP, 26.9% had a poor response, 23.1% had a good response and 26.9% had a very good response. The mean variation between PaO2/FiO2 before and after PP was 21.27%.

The inferential analysis showed that oxygenation differs significantly between the three moments of assessment of patients undergoing PP, observing significant differences between the mean PaO2/FiO2 ratios before, during and after PP until the third cycle of PP (Table 1).

Table 1

Repeated measures ANOVA test to compare the mean of the PaO2/FiO2 ratio at three assessment times, Penafiel, Portugal, 2020 (N = 52)

Dependent variables Cycle N PP Mean ± dp Z p Eta partial square Power observed
P/F (T0) 1 112.59 ± 38.24 21.198 0.000 0.306 1.000
P/F (T1) 168.06 ± 69.9
P/F (T2) 156.98 ± 46.96
P/F (T0) 2 130.85 ± 34.31 8.46 0.001 0.204 0.959
P/F (T1) 168.50 ± 64.93
P/F (T2) 145.79 ± 48.94
P/F (T0) 3 117.35 ± 27.05 13.831 0.000 0.386 0.997
P/F (T1) 167.17 ± 59.55
P/F (T2) 135 ± 38.50
P/F (T0) 4 117.71 ± 34.39 3.827 0.35 0.227 0.643
P/F (T1) 141.5 ± 43.58
P/F (T2) 120.29 ± 54.61
P/F (T0) 5 84.67 ± 46.1 0.336 0.72 0.46 0.093
P/F (T1) 100.5 ± 42.5
P/F (T2) 102.87 ± 50.71
P/F (T0) 6 78 ± 15.38 5.7 0.06 0.66 0.640
P/F (T1) 122.25 ± 42.74
P/F (T2) 86 ± 21.21

Cycle N PP – number of cycles of PP; dp – standard deviation; Z-test value; p – likelihood; Eta partial square – effect size; T0 – before PP, T1 – during PP, T2 – after PP (on return to DD).

Regarding the effects of PP characteristics and disease chronology on the response to PP, an adjusted ordinal model was found to be equal to −0.456 for the number of PP cycles, and −0.020 for the timing to OTI, i.e. the response to PP is inversely proportional to the number of PP cycles and the timing to OTI. For the remaining variables of disease chronology and PP characteristics, there was no ordinal adjusted model (p > 0.05). According to the model, as the timing to OTI and the number of cycles of PP increase, the probability values of a higher response to PP are 0.036 and 0.009, respectively (Table 2).

Table 2

Ordinal regression model for parameter estimation relevant to demographic variables and clinical background under the response to PP, Penafiel, Portugal, 2020 (N = 52)

Variables Estimate Standard deviation X 2 Wald df p Confidence interval 95%
No reply to PP 4.227 3.981 1.127 1 0.288 [−3.576; 12.031]
Poor response to PP 5.687 4.026 1.996 1 0.158 [−2.203; 13.577]
Good response to PP 6.943 4.059 2.926 1 0.087 [−1.012; 14.898]
No smoking 2.219 1.028 4.660 1 0.031 [0.204; 4.234]

df – degrees of freedom; p – probability.

The model is statistically significant (χ 2 = 13.914; p = 0.031), and the effect size is small (McFadden = 0.097; NagelKerke = 0.251; Cox and Snell = 0.235). Regarding the influence of demographic variables and relevant clinical history on the response to PP, an ordinal adjusted model (= +2.219, no Smoking) was found. For the remaining demographic variables and relevant clinical history, an ordinal adjusted model was not found (p > 0.05). According to the model, as the proportion of patients with no history of smoking increases, the probability of observing a higher response to PP is 0.031 (Table 3).

Table 3

Ordinal regression model for estimates of the parameter’s chronology of illness and PP characteristics under the response to PP, Penafiel, Portugal, 2020 (N = 52)

Variables Estimate Standard deviation X2 Wald df p Confidence interval 95%
No reply to PP −0.324 1.634 0.039 1 0.843 [−3.526; 2.879]
Poor response to PP 1.105 1.636 0.456 1 0.500 [−2.102; 4.311]
Good response to PP 2.293 1.663 1.901 1 0.168 [−0.966; 5.551]
Timing to EOT −0.020 0.009 4.379 1 0.036 [−0.038; −0.001]
No. of PP cycles −0.456 0.175 6.750 1 0.009 [−0.800; −0.112]

df – degrees of freedom; p – probability.

However, the model is not statistically significant (χ 2 = 16.340; p = 0.219) and the effect size is small (McFadden = 0.114; NagelKerke = 0.288; Cox and Snell = 0.270).

Finally, regarding the outcome of patients, we found that the mean scores for the duration of IMV and length of stay in the MICU of patients with different responses to PP did not differ significantly (p = 0.123 and 0.263) (Table 4).

Table 4

Kruskal–Wallis test to compare the mean rank of IMV time and length of stay of patients in the MICU according to the response to PP, Penafiel, Portugal, 2020 (N = 52)

Dependent variable Response to PP N Mean rank Test value df p
IMV time No 12 22.33 KW = 5.782 3 0.123
Weak 14 30.07
Good 12 32.17
Very good 14 21.64
Length of stay in MICU No 12 21.58 KW = 3.989 3 0.263
Weak 14 29.57
Good 12 30.38
Very good 14 24.32

KW – Kruskal–Wallis.

There were also no statistically significant differences regarding the incidence of tracheostomy and mortality (χ 2: p ≥ 0.172; 0.148) (Table 5).

Table 5

χ 2 test for differences between the proportions of the categories of nominal dependent variables of hypothesis H4 as a function of response to PP, Penafiel, Portugal, 2020 (N = 52)

Dependent variables Response to PP n Test value df p
No Weak Good Very good
Tracheostomy
No AR 11 (91.7%) 9 (64.3%) 10 (83.3%) 13 (92.9%) 43 χ 2 = 5.004 3 0.172a
0.9 −2.1 −0.1 −1.2
Yes AR 1 (8.3%) 5 (35.7%) 2 (16.7%) 1 (7.1%) 9
−0.9 2.1 −0.1 −1.2
Result
Deceased AR 9 (75%) 8 (57.1%) 6 (50%) 3 (21.4%) 26 9.482 6 0.148ª
2 0.6 0 −2.5
Hospital transfer AR 1 (8.3%) 0 (0.0%) 1 (8.3%) 1 (8.3%) 3
0.4 −1.1 0.4 0.3
Improved AR 2 (16.7%) 6 (42.9%) 5 (41.7%) 10 (71.4%) 23
−2.2 −0.1 −0.2 2.4

n – absolute frequency; df – degrees of freedom; p – probability; AR – adjusted residual; a – Pearson’s Chi-square test.

It should be noted that PP was performed by maintaining hemodynamic stability, and there was only a slight increase in the mean arterial pressure (MAP) and heart rate (HR) after PP. A total of 143 PP were performed, with complications arising in only 16.2% of the PP performed, which mainly occurred in the first and second PP cycles, the most frequent being edema of the face/eyes/lips (39.1%), followed by pressure ulcers (PU) (30.4%).

4 Discussion

The profile of patients who developed a severe disease and underwent PP is in line with that described in the literature, being characterized by elderly male patients, with a clinical history of HT, DM and obesity, with a high nursing workload index [2,12,15,16,19]. With regard to gender, although the current knowledge is still very limited, some studies point out that male patients with SARS-cov-2 pneumonia tend to have a higher mortality rate [21,22]. However, the response to PP does not seem to be influenced by gender. However, in conscious patients who underwent PP, it was considered a favorable procedure predominantly by females (73% females versus 56.5% males), which seems to be related to differences in literacy and educational attainment [22].

The PP was performed according to recommendations [4,9,10,11,12] at the time in force, with the first PP cycle occurring 45.7 ± 61.2(21) h after OTI, with each patient performing an average of 2.8 ± 1.6 cycles lasting 20.5 ± 3.7 h. The mean PaO2/FiO2 ratio before starting PP was 115.6 ± 38.2; at PP, the ratio was 159.1 ± 65.4 and after undoing PP, the ratio was 140.1 ± 48.9, showing an improvement of oxygenation with PP. The mean increase between PaO2/FiO2 before and after PP was 21.27%. In other studies on the subject, PP was also associated with improvement in oxygenation [6,14,23,24], with a mean variation between PaO2/FiO2 before and after PP higher than that observed in this study (49%) [21], maintaining the improvement of oxygenation on return to the DD, starting PP earlier, with a mean PaO2/FiO2 ratio before starting the PP of 150 (IQR, 125–183), in PP of 232 (IQR, 174–304) and after undoing PP of 217 (IQR, 149–263), performing each patient 2 (3–5) sessions of PP with an average of 18 h (IQR, 16–22 h) per session[4], 3 cycles been necessary with about 36 h in other studies [3].

As expected and observed in other studies, PP was found to improve the PaO2/FiO2 ratio in patients with SARS-Cov-2 pneumonia [4,6,14,21,24,25]. However, significant differences between mean PaO2/FiO2 ratios before, during and after PP are only observed up to the third PP cycle. From the fourth cycle onwards, the PaO2/FiO2 ratio (T0) starts decreasing and PP is not sufficient to reverse hypoxia. It was found that the response to PP is inversely proportional to the number of PP cycles and OTI timing. In other studies, it was found that by prolonging the stay in PP up to 36 h, a reduction in the number of cycles of PP was achieved, which translated into an improvement in the PaO2/FiO2 ratio, which was perpetuated upon the return to DD [23]. Other authors found, through a systematic review of literature, that PP improved oxygenation in patients under IMV, from the second cycle and in prolonged episodes of PP [26] but no study refers to the decrease in the efficacy of PP with the increase in the number of cycles, nor to the underlying mechanisms.

Despite the high incidence of relevant clinical history and demographic differences observed as a function of response to PP, contrary to expectations, it was found that the response to PP is not influenced by these variables. On the other hand, it was observed that response to PP did not influence the patient outcome, with no significant differences in IMV time, length of stay, incidence of tracheostomy and mortality. Although these results differ from what was expected for this study, other researchers also observed that 80% of patients had improved oxygenation with PP, although there was no correlation between this improvement and clinical improvement [4], with only a trend toward a non-significant reduction in mortality (OR: 0.76; 95% CI: 0.54–1.06; p = 0.11, I2 63%) [8].

It should be noted that PP was performed without hemodynamic repercussions, with complications occurring in only 16.2% of the PP performed, suggesting that it is safe to be performed.

This study characterized patients with SARS-Cov-2 pneumonia, described the use of PP as an alveolar recruitment maneuver in these situations and characterized the response to PP based on its effects on oxygenation to understand the influence of demographic variables, relevant clinical history and disease chronology, as well to analyze their impact on patient outcomes.

The results observed have implications for the care of critically ill patients with SARS-Cov-2 pneumonia because, in addition to having demonstrated that PP is a safe procedure that improves oxygenation in these patients, it also showed that multiple PP sessions are not beneficial. Alternative treatments should be considered for patients requiring more than three cycles of PP, and it is essential to avoid delaying OTI in order to improve the response to PP.



Acknowledgments

We would like to thank the hospital centre for their support.

  1. Funding information: This study had the financial support of CIEC (Research Centre on Child Studies), by the Strategic Project UID/CED/00317/2013, through the National Funds through the FCT (Foundation for Science and Technology) and co-financed by European Regional Development Funds (FEDER) through the Competitiveness and Internationalization Operational Program (POCI) with the reference POCI-01-0145-FEDER-007562. This study also had the financial support of Tâmega and Sousa Hospital Center, Penafiel, Portugal.

  2. Author contributions: Study conception and design: SMRO, AF, PS. Data collection: SMRO, AF, PS. Data analysis and interpretation: SMRO, AASC. Drafting of the article: SMRO, AASC. Critical revision of the article: CP, MGC, AASC.

  3. Conflict of interest: There is no conflict of interest. One of the authors (AASC) is an editor with Open Medicine but this did not affect the peer review process, and we were not aware of who the peer reviewers were.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the author Sandra Oliveira on reasonable request.

References

[1] Yamayoshi S, Sakai-Tagawa Y, Koga M, Akasaka O, Nakachi I, Koh H, et al. Comparison of rapid antigen tests for COVID-19. Viruses. 2020;12(1420):1–8. 10.3390/v12121420.Suche in Google Scholar PubMed PubMed Central

[2] Song C, Li Z, Li C, Huang M, Liu J, Fang Q, et al. SARS-CoV-2: The monster causes COVID-19, frontiers in cellular and infection. Microbiology. 2022;12:1–7. 10.3389/fcimb.2022.835750.Suche in Google Scholar PubMed PubMed Central

[3] Moreno F, Khouri L, Guzmán C, Acosta B, Sánchez J, Granillo J. Posición prono en pacientes con síndrome de insuficiencia respiratoria progressiva aguda por COVID-19. Med Critic. 2020;34(1):73–7. 10.35366/93283.Suche in Google Scholar

[4] Ziehr D, Alladina J, Petri C, Maley J, Moskowitz A, Medoff B, et al. Respiratory pathophysiology of mechanically ventilated patients with COVID-19: A cohort study. Am J Respir Crit Care Med. 2020;201(12):1560–4. 10.1164/rccm.202004-1163LE.Suche in Google Scholar PubMed PubMed Central

[5] Centers for Diesease Control and Prevention. Underlying medical conditions associated with high risk for severe COVID-19: information for healthcare providers. [Internet]; 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html [cited 2022 Nov 10].Suche in Google Scholar

[6] Mora- Arteaga JA, Bernal-Ramirez OJ, Rodriguez SJ. The effects of prone position ventilation in patients with acute respiratory distress syndrome. A systematic review and metaanalysis. Med Intensiva. 2015;39(6):359–72. 10.1016/j.medine.2014.11.004.Suche in Google Scholar

[7] Griffiths M, McAuley D, Perkins D, Barrett B, Blackwood B, Boyle A, et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respir Res. 2019;6:1–27. 10.1136/bmjresp-2019-000420.Suche in Google Scholar PubMed PubMed Central

[8] Intensive Care Society Care Society. Guidance for: prone positioning in adult critical care. [Internet]; 2019. https://www.wyccn.org/uploads/6/5/1/9/65199375/icsficm_proning_guidance_final_2019.pdf [cited 2029 Jun 30].Suche in Google Scholar

[9] Papazian L, Aubron C, Brochard L, Chiche J, Combes A, Dreyfuss D, et al. Formal guidelines: management of acute respiratory distress syndrome. Ann Intensive Care. 2019;9(69):1–18. 10.1186/s13613-019-0540-9.Suche in Google Scholar PubMed PubMed Central

[10] Ranieri VM, Rubenfeld G, Thompson T, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: The Berlin definition. JAMA. 2012;307(23):2526–33. 10.1001/jama.2012.5669.Suche in Google Scholar PubMed

[11] Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong M, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020;46:854–87. 10.1007/s00134-020-06022-5.Suche in Google Scholar PubMed PubMed Central

[12] World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. [Internet]; 2020. https://www.who.int/publications-detail-redirect/10665-332299 [cited 2022 Dec 30].Suche in Google Scholar

[13] Sociedade Portuguesa de Cuidados Intensivos. Recomendações para a abordagem do COVID-19: Oxigenoterapia e Suporte Respiratório.SPCI. [Internet]; 2020. https://www.spci.pt/media/covid-19/COVID_19_R_20200416.pdf [cited 2021 Jan 20].Suche in Google Scholar

[14] Carsetti A, Paciarini A, Marini B, Pantanetti S, Adrario E, Donati A. Prolonged prone position ventilation for SARS_Cov-2 patients is feasible and effective. Crit Care. 2020;24:255–7. 10.1186/s13054-020-02956-w.Suche in Google Scholar PubMed PubMed Central

[15] Bamford P, Bentley A, Dean J, Whitmore D, Wilson-Baig N. Intensive Care Society Guidance for prone positioning of the conscious COVID patient 2020 [Internet]; 2020. https://emcrit.org/wp-content/uploads/2020/04/2020-04-12-Guidance-for-conscious-proning.pdf [cited 2021 Mar 13].Suche in Google Scholar

[16] Venus K, Munshi L, Fralick M. Prone position for patients with hypoxic respiratory failure related to COVID-19. CMAJ. 2020;192(47):1532–7. 10.1503/cmaj.201201.Suche in Google Scholar PubMed PubMed Central

[17] Doussot A, Ciceron F, Cerutti E, Mont L, Thines L, Capellier G, et al. Prone positioning for severe acute respiratory distress syndrome in COVID-19 patients by a dedicated team. Ann Surg. 2020;272(6):311–5. 10.1097/SLA.0000000000004265.Suche in Google Scholar PubMed PubMed Central

[18] Ferrando C, Suarez-Spmann F, Mellado-Artigas R, Hernández M, Gea A, Arruti E, et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med. 2020;46:2200–11. 10.1007/s00134-020-06192-2.Suche in Google Scholar PubMed PubMed Central

[19] Gattioni L, Coppola S, Cressioni M, Busana M, Rossi S, Chiumello D. Covid-19 does not lead to a “Typical” acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;201(10):1299–300. 10.1164/rccm.202003-0817LE.Suche in Google Scholar PubMed PubMed Central

[20] Fortin MF, Côté J, Filion F. Fundamentos e etapas do processo de investigação. Loures: Lusodidacta; 2009.Suche in Google Scholar

[21] Scarmuzzo G, Gamberini G, Tonetti T, Zani G, Ottaviani I, Mazzoli C, et al. Sustained oxygenation improvement after first prone positioning is associated with liberation from mechanical ventilation and mortality in critically ill COVID-19 patients: a cohort study. Ann Intensive Care. 2021;11(63):1–10. 10.1186/s13613-021-00853-1.Suche in Google Scholar PubMed PubMed Central

[22] Jin J, Bai P, He W, Wu F, Liu X, Han D, et al. Gender differences in patients with COVID-19: Focus on severity and mortality. Front Public Health. 2020;8(152):1–6. 10.3389/fpubh.2020.00152.Suche in Google Scholar PubMed PubMed Central

[23] Corica B, Tartaglia F, Dámico T, Romiti G, Cangemi R. Sex and gender differences in community-acquired pneumonia. Intern Emerg Med. 2022;1:1575–88. 10.1007/s11.Suche in Google Scholar

[24] Sethi S, Hirani S, Iqbal R, Ahmed A. Patient’s perspective of awake proning: A cross-sectional interview-based survey from COVID-19–recovered patients. Crit Care Explor. 2022;4(12):0824. 10.1097/CCE.0000000000000824.Suche in Google Scholar PubMed PubMed Central

[25] Zang X, Wang Q, Zhou H, Liu S, Xue X. Efficacy of early prone position for COVID-19 patients with severe hypoxia: a single-center prospective cohort study. Intensive Care Med. 2020;46:1927–29. 10.1007/s00134-020-06182-4.Suche in Google Scholar PubMed PubMed Central

[26] Astasio-Picado A, Sánchez M. Effectiveness of Prone positioning in patients with COVID-19-related acute respiratory distress syndrome undergoing invasive mechanical ventilation. Appl Sci. 2021;11(10263):1–11. 10.3390/app112110263.Suche in Google Scholar

Received: 2023-02-05
Revised: 2023-05-15
Accepted: 2023-05-18
Published Online: 2023-06-27

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Research Articles
  2. Exosomes derived from mesenchymal stem cells overexpressing miR-210 inhibits neuronal inflammation and contribute to neurite outgrowth through modulating microglia polarization
  3. Current situation of acute ST-segment elevation myocardial infarction in a county hospital chest pain center during an epidemic of novel coronavirus pneumonia
  4. circ-IARS depletion inhibits the progression of non-small-cell lung cancer by circ-IARS/miR-1252-5p/HDGF ceRNA pathway
  5. circRNA ITGA7 restrains growth and enhances radiosensitivity by up-regulating SMAD4 in colorectal carcinoma
  6. WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4
  7. Up-regulation of collagen type V alpha 2 (COL5A2) promotes malignant phenotypes in gastric cancer cell via inducing epithelial–mesenchymal transition (EMT)
  8. Inhibition of TERC inhibits neural apoptosis and inflammation in spinal cord injury through Akt activation and p-38 inhibition via the miR-34a-5p/XBP-1 axis
  9. 3D-printed polyether-ether-ketone/n-TiO2 composite enhances the cytocompatibility and osteogenic differentiation of MC3T3-E1 cells by downregulating miR-154-5p
  10. Propofol-mediated circ_0000735 downregulation restrains tumor growth by decreasing integrin-β1 expression in non-small cell lung cancer
  11. PVT1/miR-16/CCND1 axis regulates gastric cancer progression
  12. Silencing of circ_002136 sensitizes gastric cancer to paclitaxel by targeting the miR-16-5p/HMGA1 axis
  13. Short-term outcomes after simultaneous gastrectomy plus cholecystectomy in gastric cancer: A pooling up analysis
  14. SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways
  15. Molecular mechanism by which the Notch signaling pathway regulates autophagy in a rat model of pulmonary fibrosis in pigeon breeder’s lung
  16. lncRNA TPT1-AS1 promotes cell migration and invasion in esophageal squamous-cell carcinomas by regulating the miR-26a/HMGA1 axis
  17. SIRT1/APE1 promotes the viability of gastric cancer cells by inhibiting p53 to suppress ferroptosis
  18. Glycoprotein non-metastatic melanoma B interacts with epidermal growth factor receptor to regulate neural stem cell survival and differentiation
  19. Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
  20. Association of osteoporosis and skeletal muscle loss with serum type I collagen carboxyl-terminal peptide β glypeptide: A cross-sectional study in elder Chinese population
  21. circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathway
  22. Delivery in a vertical birth chair supported by freedom of movement during labor: A randomized control trial
  23. UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K/AKT and MDM2/p53 signaling
  24. Metabolic resuscitation therapy in critically ill patients with sepsis and septic shock: A pilot prospective randomized controlled trial
  25. Lycopene ameliorates locomotor activity and urinary frequency induced by pelvic venous congestion in rats
  26. UHRF1-induced connexin26 methylation is involved in hearing damage triggered by intermittent hypoxia in neonatal rats
  27. LINC00511 promotes melanoma progression by targeting miR-610/NUCB2
  28. Ultra-high-performance liquid chromatography-tandem mass spectrometry analysis of serum metabolomic characteristics in people with different vitamin D levels
  29. Role of Jumonji domain-containing protein D3 and its inhibitor GSK-J4 in Hashimoto’s thyroiditis
  30. circ_0014736 induces GPR4 to regulate the biological behaviors of human placental trophoblast cells through miR-942-5p in preeclampsia
  31. Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies
  32. Effects of osteogenic growth peptide C-terminal pentapeptide and its analogue on bone remodeling in an osteoporosis rat model
  33. A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma
  34. WGCNA-based identification of potential targets and pathways in response to treatment in locally advanced breast cancer patients
  35. Radiomics model using preoperative computed tomography angiography images to differentiate new from old emboli of acute lower limb arterial embolism
  36. Dysregulated lncRNAs are involved in the progress of myocardial infarction by constructing regulatory networks
  37. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy
  38. Genetic polymorphisms of MRPS30-DT and NINJ2 may influence lung cancer risk
  39. Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis
  40. Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma
  41. Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
  42. CircRANBP17 modulated KDM1A to regulate neuroblastoma progression by sponging miR-27b-3p
  43. Exosomal miR-93-5p regulated the progression of osteoarthritis by targeting ADAMTS9
  44. Downregulation of RBM17 enhances cisplatin sensitivity and inhibits cell invasion in human hypopharyngeal cancer cells
  45. HDAC5-mediated PRAME regulates the proliferation, migration, invasion, and EMT of laryngeal squamous cell carcinoma via the PI3K/AKT/mTOR signaling pathway
  46. The association between sleep duration, quality, and nonalcoholic fatty liver disease: A cross-sectional study
  47. Myostatin silencing inhibits podocyte apoptosis in membranous nephropathy through Smad3/PKA/NOX4 signaling pathway
  48. A novel long noncoding RNA AC125257.1 facilitates colorectal cancer progression by targeting miR-133a-3p/CASC5 axis
  49. Impact of omicron wave and associated control measures in Shanghai on health management and psychosocial well-being of patients with chronic conditions
  50. Clinicopathological characteristics and prognosis of young patients aged ≤45 years old with non-small cell lung cancer
  51. TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia
  52. The dose limits of teeth protection for patients with nasopharyngeal carcinoma undergoing radiotherapy based on the early oral health-related quality of life
  53. miR-30b-5p targeting GRIN2A inhibits hippocampal damage in epilepsy
  54. Long non-coding RNA AL137789.1 promoted malignant biological behaviors and immune escape of pancreatic carcinoma cells
  55. IRF6 and FGF1 polymorphisms in non-syndromic cleft lip with or without cleft palate in the Polish population
  56. Comprehensive analysis of the role of SFXN family in breast cancer
  57. Efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in lung squamous cell carcinoma patients underwent conventional chemoradiotherapy
  58. Silencing of long noncoding RNA MIAT inhibits the viability and proliferation of breast cancer cells by promoting miR-378a-5p expression
  59. AG1024, an IGF-1 receptor inhibitor, ameliorates renal injury in rats with diabetic nephropathy via the SOCS/JAK2/STAT pathway
  60. Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition
  61. Exendin-4 regulates the MAPK and WNT signaling pathways to alleviate the osteogenic inhibition of periodontal ligament stem cells in a high glucose environment
  62. Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3
  63. The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma
  64. Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
  65. Ultrasound examination supporting CT or MRI in the evaluation of cervical lymphadenopathy in patients with irradiation-treated head and neck cancer
  66. F-box and WD repeat domain containing 7 inhibits the activation of hepatic stellate cells by degrading delta-like ligand 1 to block Notch signaling pathway
  67. Knockdown of circ_0005615 enhances the radiosensitivity of colorectal cancer by regulating the miR-665/NOTCH1 axis
  68. Long noncoding RNA Mhrt alleviates angiotensin II-induced cardiac hypertrophy phenotypes by mediating the miR-765/Wnt family member 7B pathway
  69. Effect of miR-499-5p/SOX6 axis on atrial fibrosis in rats with atrial fibrillation
  70. Cholesterol induces inflammation and reduces glucose utilization
  71. circ_0004904 regulates the trophoblast cell in preeclampsia via miR-19b-3p/ARRDC3 axis
  72. NECAB3 promotes the migration and invasion of liver cancer cells through HIF-1α/RIT1 signaling pathway
  73. The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
  74. miR-2053 inhibits the growth of ovarian cancer cells by downregulating SOX4
  75. Nucleophosmin 1 associating with engulfment and cell motility protein 1 regulates hepatocellular carcinoma cell chemotaxis and metastasis
  76. α-Hederin regulates macrophage polarization to relieve sepsis-induced lung and liver injuries in mice
  77. Changes of microbiota level in urinary tract infections: A meta-analysis
  78. Identification of key enzalutamide-resistance-related genes in castration-resistant prostate cancer and verification of RAD51 functions
  79. Falls during oxaliplatin-based chemotherapy for gastrointestinal malignancies – (lessons learned from) a prospective study
  80. Outcomes of low-risk birth care during the Covid-19 pandemic: A cohort study from a tertiary care center in Lithuania
  81. Vitamin D protects intestines from liver cirrhosis-induced inflammation and oxidative stress by inhibiting the TLR4/MyD88/NF-κB signaling pathway
  82. Integrated transcriptome analysis identifies APPL1/RPS6KB2/GALK1 as immune-related metastasis factors in breast cancer
  83. Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
  84. Circular RNA Circ_0038467 promotes the maturation of miRNA-203 to increase lipopolysaccharide-induced apoptosis of chondrocytes
  85. An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy
  86. Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
  87. Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
  88. PTPN12 down-regulated by miR-146b-3p gene affects the malignant progression of laryngeal squamous cell carcinoma
  89. miR-141-3p accelerates ovarian cancer progression and promotes M2-like macrophage polarization by targeting the Keap1-Nrf2 pathway
  90. lncRNA OIP5-AS1 attenuates the osteoarthritis progression in IL-1β-stimulated chondrocytes
  91. Overexpression of LINC00607 inhibits cell growth and aggressiveness by regulating the miR-1289/EFNA5 axis in non-small-cell lung cancer
  92. Subjective well-being in informal caregivers during the COVID-19 pandemic
  93. Nrf2 protects against myocardial ischemia-reperfusion injury in diabetic rats by inhibiting Drp1-mediated mitochondrial fission
  94. Unfolded protein response inhibits KAT2B/MLKL-mediated necroptosis of hepatocytes by promoting BMI1 level to ubiquitinate KAT2B
  95. Bladder cancer screening: The new selection and prediction model
  96. circNFATC3 facilitated the progression of oral squamous cell carcinoma via the miR-520h/LDHA axis
  97. Prone position effect in intensive care patients with SARS-COV-2 pneumonia
  98. Clinical observation on the efficacy of Tongdu Tuina manipulation in the treatment of primary enuresis in children
  99. Dihydroartemisinin ameliorates cerebral I/R injury in rats via regulating VWF and autophagy-mediated SIRT1/FOXO1 pathway
  100. Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway
  101. Low Ang-(1–7) and high des-Arg9 bradykinin serum levels are correlated with cardiovascular risk factors in patients with COVID-19
  102. Effect of maternal age and body mass index on induction of labor with oral misoprostol for premature rupture of membrane at term: A retrospective cross-sectional study
  103. Potential protective effects of Huanglian Jiedu Decoction against COVID-19-associated acute kidney injury: A network-based pharmacological and molecular docking study
  104. Clinical significance of serum MBD3 detection in girls with central precocious puberty
  105. Clinical features of varicella-zoster virus caused neurological diseases detected by metagenomic next-generation sequencing
  106. Collagen treatment of complex anorectal fistula: 3 years follow-up
  107. LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through down-regulating SP-A by sponging to miR-424
  108. Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen – An open-label, randomized trial
  109. SMOC2 plays a role in heart failure via regulating TGF-β1/Smad3 pathway-mediated autophagy
  110. A prospective cohort study of the impact of chronic disease on fall injuries in middle-aged and older adults
  111. circRNA THBS1 silencing inhibits the malignant biological behavior of cervical cancer cells via the regulation of miR-543/HMGB2 axis
  112. hsa_circ_0000285 sponging miR-582-3p promotes neuroblastoma progression by regulating the Wnt/β-catenin signaling pathway
  113. Long non-coding RNA GNAS-AS1 knockdown inhibits proliferation and epithelial–mesenchymal transition of lung adenocarcinoma cells via the microRNA-433-3p/Rab3A axis
  114. lncRNA UCA1 regulates miR-132/Lrrfip1 axis to promote vascular smooth muscle cell proliferation
  115. Twenty-four-color full spectrum flow cytometry panel for minimal residual disease detection in acute myeloid leukemia
  116. Hsa-miR-223-3p participates in the process of anthracycline-induced cardiomyocyte damage by regulating NFIA gene
  117. Anti-inflammatory effect of ApoE23 on Salmonella typhimurium-induced sepsis in mice
  118. Analysis of somatic mutations and key driving factors of cervical cancer progression
  119. Hsa_circ_0028007 regulates the progression of nasopharyngeal carcinoma through the miR-1179/SQLE axis
  120. Variations in sexual function after laparoendoscopic single-site hysterectomy in women with benign gynecologic diseases
  121. Effects of pharmacological delay with roxadustat on multi-territory perforator flap survival in rats
  122. Analysis of heroin effects on calcium channels in rat cardiomyocytes based on transcriptomics and metabolomics
  123. Risk factors of recurrent bacterial vaginosis among women of reproductive age: A cross-sectional study
  124. Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells
  125. Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients
  126. Correlation between microvessel maturity and ISUP grades assessed using contrast-enhanced transrectal ultrasonography in prostate cancer
  127. The protective effect of caffeic acid phenethyl ester in the nephrotoxicity induced by α-cypermethrin
  128. Norepinephrine alleviates cyclosporin A-induced nephrotoxicity by enhancing the expression of SFRP1
  129. Effect of RUNX1/FOXP3 axis on apoptosis of T and B lymphocytes and immunosuppression in sepsis
  130. The function of Foxp1 represses β-adrenergic receptor transcription in the occurrence and development of bladder cancer through STAT3 activity
  131. Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU
  132. Calycosin protects against chronic prostatitis in rats via inhibition of the p38MAPK/NF-κB pathway
  133. Pan-cancer analysis of the PDE4DIP gene with potential prognostic and immunotherapeutic values in multiple cancers including acute myeloid leukemia
  134. The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
  135. Circ-UBR4 regulates the proliferation, migration, inflammation, and apoptosis in ox-LDL-induced vascular smooth muscle cells via miR-515-5p/IGF2 axis
  136. Clinical characteristics of current COVID-19 rehabilitation outpatients in China
  137. Luteolin alleviates ulcerative colitis in rats via regulating immune response, oxidative stress, and metabolic profiling
  138. miR-199a-5p inhibits aortic valve calcification by targeting ATF6 and GRP78 in valve interstitial cells
  139. The application of iliac fascia space block combined with esketamine intravenous general anesthesia in PFNA surgery of the elderly: A prospective, single-center, controlled trial
  140. Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
  141. The effects of progesterone on the healing of obstetric anal sphincter damage in female rats
  142. Identification of cuproptosis-related genes for predicting the development of prostate cancer
  143. Lumican silencing ameliorates β-glycerophosphate-mediated vascular smooth muscle cell calcification by attenuating the inhibition of APOB on KIF2C activity
  144. Targeting PTBP1 blocks glutamine metabolism to improve the cisplatin sensitivity of hepatocarcinoma cells through modulating the mRNA stability of glutaminase
  145. A single center prospective study: Influences of different hip flexion angles on the measurement of lumbar spine bone mineral density by dual energy X-ray absorptiometry
  146. Clinical analysis of AN69ST membrane continuous venous hemofiltration in the treatment of severe sepsis
  147. Antibiotics therapy combined with probiotics administered intravaginally for the treatment of bacterial vaginosis: A systematic review and meta-analysis
  148. Construction of a ceRNA network to reveal a vascular invasion associated prognostic model in hepatocellular carcinoma
  149. A pan-cancer analysis of STAT3 expression and genetic alterations in human tumors
  150. A prognostic signature based on seven T-cell-related cell clustering genes in bladder urothelial carcinoma
  151. Pepsin concentration in oral lavage fluid of rabbit reflux model constructed by dilating the lower esophageal sphincter
  152. The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
  153. Tanshinone IIA attenuates valvular interstitial cells’ calcification induced by oxidized low density lipoprotein via reducing endoplasmic reticulum stress
  154. AS-IV enhances the antitumor effects of propofol in NSCLC cells by inhibiting autophagy
  155. Establishment of two oxaliplatin-resistant gallbladder cancer cell lines and comprehensive analysis of dysregulated genes
  156. Trial protocol: Feasibility of neuromodulation with connectivity-guided intermittent theta-burst stimulation for improving cognition in multiple sclerosis
  157. LncRNA LINC00592 mediates the promoter methylation of WIF1 to promote the development of bladder cancer
  158. Factors associated with gastrointestinal dysmotility in critically ill patients
  159. Mechanisms by which spinal cord stimulation intervenes in atrial fibrillation: The involvement of the endothelin-1 and nerve growth factor/p75NTR pathways
  160. Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics
  161. Silencing USP19 alleviates cigarette smoke extract-induced mitochondrial dysfunction in BEAS-2B cells by targeting FUNDC1
  162. Menstrual irregularities associated with COVID-19 vaccines among women in Saudi Arabia: A survey during 2022
  163. Ferroptosis involves in Schwann cell death in diabetic peripheral neuropathy
  164. The effect of AQP4 on tau protein aggregation in neurodegeneration and persistent neuroinflammation after cerebral microinfarcts
  165. Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
  166. Analysis of clinical characteristics in proximal and distal reflux monitoring among patients with gastroesophageal reflux disease
  167. Exosomal circ-0020887 and circ-0009590 as novel biomarkers for the diagnosis and prediction of short-term adverse cardiovascular outcomes in STEMI patients
  168. Upregulated microRNA-429 confers endometrial stromal cell dysfunction by targeting HIF1AN and regulating the HIF1A/VEGF pathway
  169. Bibliometrics and knowledge map analysis of ultrasound-guided regional anesthesia
  170. Knockdown of NUPR1 inhibits angiogenesis in lung cancer through IRE1/XBP1 and PERK/eIF2α/ATF4 signaling pathways
  171. D-dimer trends predict COVID-19 patient’s prognosis: A retrospective chart review study
  172. WTAP affects intracranial aneurysm progression by regulating m6A methylation modification
  173. Using of endoscopic polypectomy in patients with diagnosed malignant colorectal polyp – The cross-sectional clinical study
  174. Anti-S100A4 antibody administration alleviates bronchial epithelial–mesenchymal transition in asthmatic mice
  175. Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma
  176. Prevalence and antibiogram of bacteria causing urinary tract infection among patients with chronic kidney disease
  177. Reactive oxygen species within the vaginal space: An additional promoter of cervical intraepithelial neoplasia and uterine cervical cancer development?
  178. Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma
  179. A new technique for uterine-preserving pelvic organ prolapse surgery: Laparoscopic rectus abdominis hysteropexy for uterine prolapse by comparing with traditional techniques
  180. Self-isolation of an Italian long-term care facility during COVID-19 pandemic: A comparison study on care-related infectious episodes
  181. A comparative study on the overlapping effects of clinically applicable therapeutic interventions in patients with central nervous system damage
  182. Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome: Long-term follow-up
  183. The diagnostic accuracy of touch imprint cytology for sentinel lymph node metastases of breast cancer: An up-to-date meta-analysis of 4,073 patients
  184. Mortality associated with Sjögren’s syndrome in the United States in the 1999–2020 period: A multiple cause-of-death study
  185. CircMMP11 as a prognostic biomarker mediates miR-361-3p/HMGB1 axis to accelerate malignant progression of hepatocellular carcinoma
  186. Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations
  187. KMT2A maintains stemness of gastric cancer cells through regulating Wnt/β-catenin signaling-activated transcriptional factor KLF11
  188. Evaluation of placental oxygenation by near-infrared spectroscopy in relation to ultrasound maturation grade in physiological term pregnancies
  189. The role of ultrasonographic findings for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer
  190. Construction of immunogenic cell death-related molecular subtypes and prognostic signature in colorectal cancer
  191. Long-term prognostic value of high-sensitivity cardiac troponin-I in patients with idiopathic dilated cardiomyopathy
  192. Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients
  193. Integrative bioinformatics analysis reveals STAT2 as a novel biomarker of inflammation-related cardiac dysfunction in atrial fibrillation
  194. Adipose-derived stem cells repair radiation-induced chronic lung injury via inhibiting TGF-β1/Smad 3 signaling pathway
  195. Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000–2016 cohort
  196. lncRNA LENGA sponges miR-378 to promote myocardial fibrosis in atrial fibrillation
  197. Diagnostic value of urinary Tamm-Horsfall protein and 24 h urine osmolality for recurrent calcium oxalate stones of the upper urinary tract: Cross-sectional study
  198. The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer
  199. The spike protein of SARS-CoV-2 induces inflammation and EMT of lung epithelial cells and fibroblasts through the upregulation of GADD45A
  200. Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
  201. MiR-1278 targets CALD1 and suppresses the progression of gastric cancer via the MAPK pathway
  202. Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson’s disease after dietary supplementation with branched-chain amino acids
  203. Cimifugin inhibits adipogenesis and TNF-α-induced insulin resistance in 3T3-L1 cells
  204. Predictors of gastrointestinal complaints in patients on metformin therapy
  205. Prescribing patterns in patients with chronic obstructive pulmonary disease and atrial fibrillation
  206. A retrospective analysis of the effect of latent tuberculosis infection on clinical pregnancy outcomes of in vitro fertilization–fresh embryo transferred in infertile women
  207. Appropriateness and clinical outcomes of short sustained low-efficiency dialysis: A national experience
  208. miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD
  209. Clinical features and management of lymphoepithelial cyst
  210. Serum VEGF, high-sensitivity CRP, and cystatin-C assist in the diagnosis of type 2 diabetic retinopathy complicated with hyperuricemia
  211. ENPP1 ameliorates vascular calcification via inhibiting the osteogenic transformation of VSMCs and generating PPi
  212. Significance of monitoring the levels of thyroid hormone antibodies and glucose and lipid metabolism antibodies in patients suffer from type 2 diabetes
  213. The causal relationship between immune cells and different kidney diseases: A Mendelian randomization study
  214. Interleukin 33, soluble suppression of tumorigenicity 2, interleukin 27, and galectin 3 as predictors for outcome in patients admitted to intensive care units
  215. Identification of diagnostic immune-related gene biomarkers for predicting heart failure after acute myocardial infarction
  216. Long-term administration of probiotics prevents gastrointestinal mucosal barrier dysfunction in septic mice partly by upregulating the 5-HT degradation pathway
  217. miR-192 inhibits the activation of hepatic stellate cells by targeting Rictor
  218. Diagnostic and prognostic value of MR-pro ADM, procalcitonin, and copeptin in sepsis
  219. Review Articles
  220. Prenatal diagnosis of fetal defects and its implications on the delivery mode
  221. Electromagnetic fields exposure on fetal and childhood abnormalities: Systematic review and meta-analysis
  222. Characteristics of antibiotic resistance mechanisms and genes of Klebsiella pneumoniae
  223. Saddle pulmonary embolism in the setting of COVID-19 infection: A systematic review of case reports and case series
  224. Vitamin C and epigenetics: A short physiological overview
  225. Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients
  226. Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
  227. Mechanism of rhubarb in the treatment of hyperlipidemia: A recent review
  228. Surgical management and outcomes of traumatic global brachial plexus injury: A concise review and our center approach
  229. The progress of autoimmune hepatitis research and future challenges
  230. METTL16 in human diseases: What should we do next?
  231. New insights into the prevention of ureteral stents encrustation
  232. VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature
  233. Case Reports
  234. Mycobacterium xenopi infection of the kidney and lymph nodes: A case report
  235. Genetic mutation of SLC6A20 (c.1072T > C) in a family with nephrolithiasis: A case report
  236. Chronic hepatitis B complicated with secondary hemochromatosis was cured clinically: A case report
  237. Liver abscess complicated with multiple organ invasive infection caused by hematogenous disseminated hypervirulent Klebsiella pneumoniae: A case report
  238. Urokinase-based lock solutions for catheter salvage: A case of an upcoming kidney transplant recipient
  239. Two case reports of maturity-onset diabetes of the young type 3 caused by the hepatocyte nuclear factor 1α gene mutation
  240. Immune checkpoint inhibitor-related pancreatitis: What is known and what is not
  241. Does total hip arthroplasty result in intercostal nerve injury? A case report and literature review
  242. Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi – Case report and literature review
  243. Synchronous triple primary gastrointestinal malignant tumors treated with laparoscopic surgery: A case report
  244. CT-guided percutaneous microwave ablation combined with bone cement injection for the treatment of transverse metastases: A case report
  245. Malignant hyperthermia: Report on a successful rescue of a case with the highest temperature of 44.2°C
  246. Anesthetic management of fetal pulmonary valvuloplasty: A case report
  247. Rapid Communication
  248. Impact of COVID-19 lockdown on glycemic levels during pregnancy: A retrospective analysis
  249. Erratum
  250. Erratum to “Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway”
  251. Erratum to: “Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p”
  252. Retraction
  253. Retraction of “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients”
  254. Retraction of “circ_0062491 alleviates periodontitis via the miR-142-5p/IGF1 axis”
  255. Retraction of “miR-223-3p alleviates TGF-β-induced epithelial-mesenchymal transition and extracellular matrix deposition by targeting SP3 in endometrial epithelial cells”
  256. Retraction of “SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis”
  257. Retraction of “circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury”
  258. Retraction of “lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells”
  259. Special issue Linking Pathobiological Mechanisms to Clinical Application for cardiovascular diseases
  260. Effect of cardiac rehabilitation therapy on depressed patients with cardiac insufficiency after cardiac surgery
  261. Special issue The evolving saga of RNAs from bench to bedside - Part I
  262. FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma
  263. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part III
  264. Development of a machine learning-based signature utilizing inflammatory response genes for predicting prognosis and immune microenvironment in ovarian cancer
Heruntergeladen am 8.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/med-2023-0735/html
Button zum nach oben scrollen